ArticleFrontiers in cellular and infection microbiology2025
tNGS-based detection of respiratory pathogens in a single center: associations with age, gender, season, and co-infections.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Analytic and Diagnostic Validation of a Targeted Next-Generation Sequencing Panel for Common and Emerging Swine Respiratory Pathogens.Microorganisms · 2026Article
- Streptococcus pyogenes-Induced Necrotizing Pneumonia With Pleural Effusion in a Child: Role of Medical Thoracoscopy.The American journal of case reports · 2026Article
- Microbial spectrum, co-detection patterns, and clinical correlations in 10,153 hospitalized children with acute respiratory infections: a large-scale tNGS analysis.Journal of translational medicine · 2026Article
- Pathogen prevalence, feature composition and cross-centre generalisability of machine learning diagnostic models for multi-pathogen respiratory infection.Frontiers in public health · 2026Article
- Clinical Impact of Polymicrobial Interactions in Human-Metapneumovirus-Infected Children: A Targeted Next-Generation Sequencing Based Retrospective Study.Infection and drug resistance · 2026Article
- Diagnostic Insights Into Pathogen Spectrum and Mixed Microbial Detection in Critically Ill Patients With Pulmonary Infection Using Targeted Next-Generation Sequencing.Canadian respiratory journal · 2026Article
- Application value of next generation sequencing technology for pathogen detection in patients with pulmonary infection and lung cancer.American journal of cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory tract infections represent a significant global health challenge. Conventional diagnostic methods frequently fail to detect complex infections or novel pathogens. This study employed Targeted Next-Generation Sequencing to achieve an unbiased and comprehensive identification of respiratory pathogens, as well as to conduct analysis of pathogen distribution across age, gender and seasons. Methods: We conducted a retrospective analysis of clinical samples, including throat swabs, sputum, and bronchoalveolar lavage fluid, obtained from symptomatic patients. The analysis utilized targeted next-generation sequencing in conjunction with bioinformatics. Statistical assessments were performed to evaluate associations with age, gender, season, and co-infections, primarily employing Chi-square tests. Results: A high pathogen detection rate of 97.08% was achieved among 20059 individuals. Bacteria were the most frequently detected pathogens, accounting for 49.62%, followed by viruses at 43.31%, and special pathogens at 7.07%. Significant age-related differences in pathogen profiles were observed. Although no overall gender effect was detected, variations specific to certain pathogens were noted. Clear seasonal trends emerged for key pathogens. Co-infections were highly prevalent, with bacterial-viral combinations being the most common, affecting 49.03% of patients, which exceeded the rate of bacterial infections alone at 15.69%. Conclusion: Targeted next-generation sequencing serves as a robust tool for elucidating the intricate spectrum and epidemiology of respiratory pathogens. This study underscores significant associations with patient age, seasonal variations, and the prevalence of co-infections, providing essential insights for targeted clinical and public health interventions in response to respiratory tract infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.